Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study

oleh: Yuliya Lytvyn, PhD, Hiba Zaaroura, MD, Asfandyar Mufti, MD, Shaikhah AlAbdulrazzaq, MD, Jensen Yeung, MD, FRCPC

Format: Article
Diterbitkan: Elsevier 2021-09-01

Deskripsi

Subjek

biologic; drug survival; guselkumab; IL-23 inhibitor